Deterioration of lung function is the most frequent cause
of death in SSc. Alveolitis is considered the initiating
event of SSc lung fibrosis. Effective therapy of SSc
alveolitis is, therefore, of paramount importance. Here
we assessed the use of intravenous CYC on pulmonary
function testing(PFT) and high resolution computerized
tomography (HRCT) abnormalities in 15 patients with
SSc and alveolitis.
Weinberg, MD, Nicole; Sandorfi, MD, Nora; and Jimenez, MD, Sergio A.
"Effect Of Intravenous Pulse Cyclophosphamtoe (CYC) Therapy On Systemic Sclerosis (Ssc) Inflammatory Lung Disease,"
The Medicine Forum:
Vol. 5, Article 17.
Available at: http://jdc.jefferson.edu/tmf/vol5/iss1/17